C07C 59/50
Mandelic acid
C07C59/50 (Mandelic acid) appears on 32 US grants and 47 published applications in this corpus.
Search patents in C07C- Granted patents
- 32
- Published applications
- 47
- Assignees
- 36
- Inventors
- 160
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 3 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 2 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 2 | 1 |
| 2011 | 0 | 4 |
| 2012 | 0 | 4 |
| 2013 | 1 | 1 |
| 2014 | 1 | 1 |
| 2015 | 2 | 3 |
| 2016 | 2 | 1 |
| 2017 | 3 | 5 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 4 | 3 |
| 2021 | 2 | 1 |
| 2022 | 0 | 4 |
| 2023 | 2 | 5 |
| 2024 | 3 | 6 |
| 2025 | 2 | 2 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Process for preparing solriamfetol hydrochloride1 Sep 2026US 12,723,020 B2Procos S.P.A.
- Polymorphs of 7-cyclopentyl-N,N-dimethyl-2-{[5-(piperazin-1-yl) pyridin-2-yl]-amino}-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide and its pharmaceutically acceptable salts and process for the preparation thereof18 Nov 2025US 12,473,292 B2Msn Laboratories Private Limited, R&D Center
- Polymorphs of phenyl pyrrole aminoguandium salts4 Mar 2025US 12,239,631 B2Synact Pharma APS
- Stable psilocin salts, esters and conjugates and uses thereof31 Dec 2024US 12,178,801 B1Lobe Sciences Ltd.
- Methods and intermediates for preparing therapeutic compounds22 Oct 2024US 12,122,765 B2Gilead Sciences, Inc.
- Salts and solid forms of (s)- or racemic 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and methods of using the same9 Apr 2026US 2026/0098035 A1Celgene Corporation
- Preparation of stable psilocin salts, esters and conjugates and uses thereof1 Jan 2026US 2026/0001841 A1Lobe Sciences Ltd.
- Salt crystals24 Apr 2025US 2025/0129087 A1Intra-Cellular Therapies, Inc.
- Methods and intermediates for preparing therapeutic compounds27 Mar 2025US 2025/0100999 A1Gilead Sciences, Inc.
- Stable psilocin salts, esters and conjugates and uses thereof19 Dec 2024US 2024/0415813 A1Lobe Sciences Ltd.
Most cited
By later US patents
- Methods and intermediates for preparing therapeutic compounds23US 10,696,657 B2Gilead Sciences, Inc. · 2020
- Methods and intermediates for preparing therapeutic compounds16US 11,117,886 B2Gilead Sciences, Inc. · 2021
- Solid forms of an HPK1 inhibitor12US 11,066,394 B2Incyte Corporation · 2021
- Atrasentan mandelate salts10US 8,962,675 B1AbbVie Inc. · 2015
- Polyvinyl ester dispersion with metal salt hydrosols as precipitation basis9US 5,889,107 AClariant GmbH · 1999